🔗 Permalink

Inventor profile of:

Kenneth A. Jacobson

City:

Silver Spring, Maryland

Country:

United States

Published Applications:

Last publication date:

2025-11-27

Top Assignees for applications by Kenneth A. Jacobson

The entities that hold a legal rights for patent applications filed by inventor Jacobson Kenneth A.:

The United States of America, as represented by the Secretary, Department of Health and Human Services 9 Washington, DC United States
The United States of America,as represented by the Secretary,Department of Health and Human Services 6 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 6 Bethesda, MD United States
University of Connecticut 3 Farmington, CT United States
The United States of America as Represented by the Department of Health and Human Services 2 Washington, DC United States
THE UNIVERSITY OF CONNECTICUT 2 Farmington, CT United States
SAINT LOUIS UNIVERSITY 2 St. Louis, MO United States
GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPA 1 Rockville, MD United States
Universita Degli Studi Di Trieste 1 Trieste, Italy
Università Degli Studi di Padova 1 Padua, Italy
Ewha Womans University 1 Seoul, South Korea
Astrocyte Pharmaceuticals, Inc. 1 Cambridge, MA United States
University of Bonn 1 Bonn, Germany
Office of Technology Transfer, NIH 1 Bethesda, MD United States
The United States of America, as represented by the Secretary, Dept. of Health and Human Services 1 Bethesda, MD United States
Government of the United States of America, repres ented by The Secretary, Department of Health and 1 Rockville, MD United States
GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT OF HEALTH AND H 1 Rockville, Moldavia
Board of Regents, The University of Texas System 1 Austin, TX United States
INSERM 1 PARIS, France
United States of America, Represented by the Secretary, Department of Health and Human Services 1 Washington, DC United States
Govt of the U.S.A., represented by the Secretary, Dept of Health & Human Services 1 Rockville, MD United States
Services 1 Bethesda, MD United States
The United States of America as Represented by the Department of Health and Human Services 1 Bethesda, MD United States
The United State of America, as represented by the Secretary, Department of Health and Human Service 1 Bethasda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Serv 1 Bethesda, MD United States
The United States of America, As Represented by the Secretary, Department of Health and Human Services, The Office of Technology Transfer, National Institutes of Health 1 Washington, DC United States
University of Münster 1 Münster, Germany
The United States of America, as represented by the Secretary ,Deptment of Health and HumanService 1 Bethesda, MD United States
UNIVERSITA DEGLI STUDI DI PADOVA 1 Padova, Italy
The United States of America as represented by the Secretary of the Department of Health and Human Services 1 Washington, DC United States
The United States of Americia, as represented by the Secretary, Department of Health and Human Serv 1 Bethesda,, MD United States
FM Therapeutics Co., Ltd. 1 Seoul, South Korea
INSERM U.311 1 Paris Cedex 13, France

Recent patent applications by Jacobson Kenneth A.

Kenneth A. Jacobson from Silver Spring, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-27

US20250360143A1

Human necessities

COMPOSITIONS AND METHODS FOR PHARMACOLOGIC TREATMENT OF STROKE AND MYOCARDIAL ISCHEMIA REPERFUSION INJURY

#2 | 2024-11-07

US20240368164A1

Chemistry; metallurgy

PURINE NUCLEOSIDES, THEIR INTERMEDIATES, AND METHODS OF PREPARATION THEREOF

#3 | 2024-05-09

US20240150290A1

Chemistry; metallurgy

HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS

#4 | 2023-11-16

US20230365568A1

Chemistry; metallurgy

PLK1 POLO BOX DOMAIN INHIBITORS AND METHOD OF TREATING CANCER

#5 | 2022-09-29

US20220305044A1

Human necessities

Compounds and methods for treating neurological and cardiovascular conditions

#6 | 2022-01-27

US20220024926A1

Chemistry; metallurgy

A1 ADENOSINE RECEPTOR AGONISTS AND METHODS OF USE THEREOF

#7 | 2021-06-10

US20210169911A1

Human necessities

PURINE AND PYRIMIDINE NUCLEOTIDES AS ECTO-5'-NUCLEOTIDASE INHIBITORS

#8 | 2021-02-18

US20210047293A1

Chemistry; metallurgy

Heterocyclic P2Yreceptor antagonists

#9 | 2018-10-18

US20180297981A1

Chemistry; metallurgy

Triazole derivatives as P2Yreceptor antagonists

#10 | 2018-10-04

US20180280409A1

Human necessities

Methods for pharmacologic treatment of stroke

#11 | 2018-08-16

US20180230150A1

Chemistry; metallurgy

A3 adenosine receptor agonists

#12 | 2017-01-05

US20170002007A1

Chemistry; metallurgy

A3 adenosine receptor agonists

#13 | 2016-06-16

US20160166591A1

Human necessities

Compositions and methods to treat cardiac diseases

#14 | 2015-02-05

US20150038463A1

Chemistry; metallurgy

Compositions and methods to treat cardiac diseases

#15 | 2013-07-25

US20130190335A1

Chemistry; metallurgy

Fluorescent antagonists of the A3 adenosine receptor

#16 | 2012-10-18

US20120264769A1

Chemistry; metallurgy

Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure

#17 | 2012-10-04

US20120252823A1

Chemistry; metallurgy

Adenosine receptor agonists, partial agonists, and antagonists

#18 | 2012-07-19

US20120184569A1

Chemistry; metallurgy

Aadenosine receptor agonists and antagonists

#19 | 2011-09-01

US20110212924A1

Human necessities

Compositions and methods to treat cardiac diseases

#20 | 2011-07-14

US20110171130A1

Chemistry; metallurgy

Aadenosine receptor antagonists and partial agonists

#21 | 2011-02-24

US20110046166A1

Chemistry; metallurgy

Purine derivatives as Aadenosine receptor-selective agonists

#22 | 2010-06-03

US20100137577A1

Chemistry; metallurgy

Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient

#23 | 2009-10-15